Bioconjugates: From Targets to Therapeutics
The dPEG® as an Integrated Bioconjugate Platform: Moving Beyond Linkers
Biocompatible, hydrophilic linker technology is a critical component of bioconjugate architecture. These linkers currently maintain the solubility of hydrophobic warheads, minimize aggregation, and optimize PK of bioconjugates like ADCs. Quanta BioDesign has developed more highly functional hydrophilic, non-immunogenic bioconjugate linker constructs with completely defined structures that incorporate key bioorthogonal chemistries with flexible lengths and sizes, allowing further performance optimization.